Cancer specialist demonstrates safety of novel agent
A novel therapy designed to help stimulate the body’s immune system response against cancer appears to be safe to use
Read more
Long-term cardiomyopathy risk varies by chemo agent
(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according
Read more
PET imaging agent may allow early measurement of efficacy of breast cancer therapy
Physicians may soon have a new way to measure the efficacy or failure of hormone therapy for breast cancer patients,
Read more